These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14984440)

  • 1. Delayed genomic and acute nongenomic action of glucocorticosteroids in seasonal allergic rhinitis.
    Tillmann HC; Stuck BA; Feuring M; Rossol-Haseroth K; Tran BM; Lösel R; Schmidt BM; Hörmann K; Wehling M; Schultz A
    Eur J Clin Invest; 2004 Jan; 34(1):67-73. PubMed ID: 14984440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine.
    Dumitru AF; Shamji M; Wagenmann M; Hindersin S; Scheckenbach K; Greve J; Klenzner T; Hess L; Nebel S; Zimmermann C; Zahner C; Schmidt-Weber CB; Chaker AM
    J Allergy Clin Immunol; 2011 Jun; 127(6):1515-21.e6. PubMed ID: 21489609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis.
    Schmidt BM; Timmer W; Georgens AC; Hilt M; Mattinger C; Wurst W; Hörmann K; Wehling M
    J Clin Pharmacol; 1999 Oct; 39(10):1062-9. PubMed ID: 10516941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis.
    Mösges R; Lehmacher W; Pasch N; Vent J
    Asian Pac J Allergy Immunol; 2009 Dec; 27(4):181-90. PubMed ID: 20232572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
    Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
    Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
    Baroody FM; Shenaq D; DeTineo M; Wang J; Naclerio RM
    J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray.
    Gawchik S; Goldstein S; Prenner B; John A
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):416-21. PubMed ID: 12722964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit.
    Horak F; Stübner UP; Zieglmayer R; Harris AG
    J Allergy Clin Immunol; 2002 Jun; 109(6):956-61. PubMed ID: 12063524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
    Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
    J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo IG; Vizzaccaro A; Tosca MA
    Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis.
    Badorrek P; Hohlfeld JM; Krug N; Joshi A; Raut A
    Ann Allergy Asthma Immunol; 2015 Oct; 115(4):325-329.e1. PubMed ID: 26272281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.
    Valero A; Serrano C; Bartrá J; Izquierdo I; Muñoz-Cano R; Mullol J; Picado C
    J Investig Allergol Clin Immunol; 2009; 19(6):488-93. PubMed ID: 20128424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pollen blocker cream in the treatment of allergic rhinitis.
    Schwetz S; Olze H; Melchisedech S; Grigorov A; Latza R
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):979-84. PubMed ID: 15313870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis.
    Schmidt BM; Kusma M; Feuring M; Timmer WE; Neuhäuser M; Bethke T; Stuck BA; Hörmann K; Wehling M
    J Allergy Clin Immunol; 2001 Oct; 108(4):530-6. PubMed ID: 11590377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mometasone furoate nasal spray for moderate-to-severe nasal congestion in subjects with seasonal allergic rhinitis.
    Meltzer EO; Shekar T; Teper AA
    Allergy Asthma Proc; 2011; 32(2):159-67. PubMed ID: 21439168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.